COMMUNIQUÉS West-GlobeNewswire

Vital Therapies Announces Second Quarter 2018 Financial Results

07/08/2018 - 22:01

- On Track for Release of VTL-308 Topline Results in Second Half of September 2018 SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company developing ELAD®, a cell- [...]

Nuvectra™ Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:01

Reports Record Algovita® Sales of $11.5 million, Up 110% YoY PLANO, Texas, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial [...]

Xenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

07/08/2018 - 22:01

Novel Epilepsy Product Candidates – XEN1101 and XEN901 – Continue to Advance in the Clinic New XEN1101 Phase 1b TMS Pharmacodynamic Data to be Presented at upcoming European Congress on Epileptology BURNABY, British [...]

Flexion Therapeutics Reports Second-Quarter 2018 Financial Results and Recent Business Highlights

07/08/2018 - 22:01

Company reported net ZILRETTA ® ( triamcinolone acetonide extended-release injectable suspension) sales of $3.8 million in Q2 representing 73% growth over Q1 Strong progress on the ZILRETTA commercial launch: 60% of [...]

Sientra Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:01

Achieves Record Net Sales of $17.6 Million Appoints Patrick F. Williams to General Manager of miraDry Business Segment Appoints Aesthetics Veteran Paul Little as Chief Financial Officer SANTA BARBARA, Calif., Aug. 07, [...]

MyoKardia to Present at the 2018 Wedbush Pacgrow Healthcare Conference

07/08/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

MacroGenics Provides Update on Corporate Progress and 2nd Quarter 2018 Financial Results

07/08/2018 - 22:01

ROCKVILLE, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

GW Pharmaceuticals plc Reports Fiscal Third Quarter 2018 Financial Results and Operational Progress

07/08/2018 - 22:01

- Epidiolex ® (cannabidiol) oral solution approved by FDA and on track to be launched in Fall - - Conference call today at 4:30 p.m. ET - LONDON and CARLSBAD, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals [...]

CytomX to Present at the 2018 Wedbush PacGrow Healthcare Conference

07/08/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]

Verrica Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:01

WEST CHESTER, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]

Genesis Healthcare Reports Strong Second Quarter 2018 Results

07/08/2018 - 22:01

KENNETT SQUARE, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results [...]

Eloxx Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update

07/08/2018 - 22:01

CTA approved in Belgium and IND open in the U.S. for investigational drug candidate, ELX-02 On track to initiate Phase 2 clinical trials in cystic fibrosis and cystinosis in 2018 Expanded Leadership Team with Global [...]

Cara Therapeutics Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:01

– Conference call today at 4:30 p.m. ET – STAMFORD, Conn., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical [...]

Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock

07/08/2018 - 22:01

NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that it is offering to sell shares of its common stock in an underwritten public offering pursuant to an [...]

Abattis Announces Share Buy Back Program

07/08/2018 - 22:00

VANCOUVER, British Columbia, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis ”) ( CSE:ATT ) ( OTC:ATTBF ) is pleased to announce that it intends to proceed with a normal course [...]

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2019 Financial Results on August 10, 2018

07/08/2018 - 22:00

Financials for First Quarter Fiscal Year 2019 Ended March 31, 2018 will be released August 9, 2018 NORTHVALE, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP [...]

TG Therapeutics, Inc. Provides Business Update and Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:00

Investor Conference Call to be Held Today, Tuesday, August 7, 2018 at 4:30pm ET NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second [...]

Assure Holdings Reports 2017 and Restated 2016 Financial Results

07/08/2018 - 19:05

– 2017 Revenue Increases by 149% to $15.8 Million – PARKER, Colo., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative [...]

CORRECTING and REPLACING -- Progressive Care to Host Conference Call on Second Quarter 2018 Financial Results and Business Update on Aug. 14

07/08/2018 - 18:53

MIAMI, Aug. 07, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Progressive Care Inc. (OTCQB:RXMD), please note in the third paragraph the question submission deadline should be [...]